Pradžia › Neuroblastoma › Ilinoisas
Neuroblastoma klinikiniai tyrimai Ilinoisas
6 tyrimai dėl Neuroblastoma ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- ir dar 4
Renkami dalyviai3 fazė
Iki 30 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT06172296International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
- Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute, Chicago
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-03 · NCT03088020Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- ir dar 4
Renkami dalyviai3 fazė
365 Days – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
Renkami dalyviai1/2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT04851119NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Comer Children's Hospital, University of Chicago, Chicago
Renkami dalyviai2 fazė
Amžius nuo 1 iki 31 · Visoms lytims · Atnaujinta 2026-07-20 · NCT06450041Neuroblastoma Biology Study
- University of Chicago, Comer Children's Hospital, Chicago
Renkami dalyviaiStebimasis tyrimas
31 Days – 99 Years · Visoms lytims · Atnaujinta 2026-03-23 · NCT01587300Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.